HARVARD BIOSCIENCE, INC. Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax
HARVARD BIOSCIENCE, INC. (HBIO) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax of -$809.00 thousand for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-03-17.
Discontinued › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax · last filed 2021-03-17
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax for fiscal 2020 was -$809.00K.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax for fiscal 2019 was -$139.00K.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax 12 month |
|---|---|
| 2020-12-31 | -$809.00K 10-K/A · filed 2021-03-17 |
| 2019-12-31 | -$139.00K 10-K/A · filed 2021-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |